Dialectical Behavior Therapy Reduces Suicidal Behavior in Adults With Autism
By Lori Solomon HealthDay Reporter
MONDAY, April 22, 2024 -- Dialectical behavior therapy (DBT) is safe and shows short-term efficacy in reducing suicidal ideation and suicide attempts in adults with suicidal behavior and autism spectrum disorder (ASD), according to a study published online April 12 in Psychological Medicine.
Anne Huntjens, from Vrije Universiteit in Amsterdam, and colleagues evaluated the effectiveness of DBT versus treatment as usual (TAU) in reducing suicidal ideation and suicide attempts among people with ASD. The analysis included 123 outpatients (18 to 65 years of age) with diagnosed ASD and suicidal behavior who were randomly assigned to DBT or TAU.
The researchers found that at the end of treatment, DBT significantly reduced both suicidal ideation and attempts versus TAU. However, at 12-month follow-up, the differences were no longer statistically significant. Both posttreatment and at 12 months, depression severity significantly decreased with DBT. No differences between the groups were seen for social anxiety. Two suicides occurred in the TAU group.
"This study demonstrated that a shortened 26-week DBT treatment was effective in autistic adults with suicidal ideation and suicide attempts," the authors write. "Specifically, participants received DBT well, as evidenced by the low attrition rate, and DBT was shown to be safe in clinical practice, as it did not provoke severe adverse events."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Globally, Suicide Risk Increased on Certain Days of the Week, Holidays
MONDAY, Oct. 28, 2024 -- Suicide risk is highest on Mondays and increases on New Year's Day in most countries, according to a study published online Oct. 23 in The...
Prenatal Cannabis Use Not Linked to Autism Spectrum Disorder
MONDAY, Oct. 28, 2024 -- Prenatal cannabis use is not associated with child autism spectrum disorder (ASD) or with child early developmental delays, according to two studies...
Risk for Sudden Cardiac Death Elevated for Patients With Psychiatric Disorders
WEDNESDAY, Oct. 23, 2024 -- Patients with psychiatric disorders have an increased rate of sudden cardiac death (SCD), according to a study published online Oct. 22 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.